<?xml version="1.0" encoding="UTF-8"?>
<evalitem filename="/home/alesch/workbench/workspace-nepomuk/KeywordExtractionPubMedEvaluation/resources/corpus/Breast_Cancer_Res_Treat/Breast_Cancer_Res_Treat-3-1-2001225.nxml" pmcid="2001225">
  <document-statistics>
    <language value="en" />
    <document-size value="3553" />
    <lexicon-size value="721" />
  </document-statistics>
  <metrics>
    <recall value="0.767" />
    <accuracy value="0.105" />
    <precision value="0.100" />
  </metrics>
  <gold-standard>
    <keyphrase term="Anastrozole" eval-status="FULL_MATCH" />
    <keyphrase term="Breast cancer" eval-status="FULL_MATCH" />
    <keyphrase term="Letrozole" eval-status="FULL_MATCH" />
    <keyphrase term="Femara" eval-status="UNMATCHED" />
    <keyphrase term="Tamoxifen" eval-status="FULL_MATCH" />
    <keyphrase term="Aromatase inhibitors" eval-status="UNMATCHED" />
  </gold-standard>
  <prediction>
    <keyphrase term="early breast cancer" eval-status="C2_SUFFIX" />
    <keyphrase term="breast cancer" eval-status="FULL_MATCH" />
    <keyphrase term="distant metastases" eval-status="UNMATCHED" />
    <keyphrase term="Secondary end points" eval-status="UNMATCHED" />
    <keyphrase term="letrozole" eval-status="FULL_MATCH" />
    <keyphrase term="anastrozole" eval-status="FULL_MATCH" />
    <keyphrase term="tamoxifen" eval-status="FULL_MATCH" />
    <keyphrase term="postmenopausal women" eval-status="UNMATCHED" />
    <keyphrase term="study" eval-status="UNMATCHED" />
    <keyphrase term="contralateral breast cancer" eval-status="C2_SUFFIX" />
    <keyphrase term="node-positive tumors" eval-status="UNMATCHED" />
    <keyphrase term="FACE trial" eval-status="UNMATCHED" />
    <keyphrase term="AIs" eval-status="UNMATCHED" />
    <keyphrase term="Eligible patients" eval-status="UNMATCHED" />
    <keyphrase term="initial therapy" eval-status="UNMATCHED" />
    <keyphrase term="follow-up" eval-status="UNMATCHED" />
    <keyphrase term="median follow-up" eval-status="UNMATCHED" />
    <keyphrase term="primary objective" eval-status="UNMATCHED" />
    <keyphrase term="treatment" eval-status="UNMATCHED" />
    <keyphrase term="analysis" eval-status="UNMATCHED" />
    <keyphrase term="events" eval-status="UNMATCHED" />
    <keyphrase term="risk" eval-status="UNMATCHED" />
    <keyphrase term="differences" eval-status="UNMATCHED" />
    <keyphrase term="clinical" eval-status="UNMATCHED" />
    <keyphrase term="lymph node-positive breast cancer" eval-status="C2_SUFFIX" />
    <keyphrase term="months" eval-status="UNMATCHED" />
    <keyphrase term="adjuvant" eval-status="UNMATCHED" />
    <keyphrase term="positive nodes" eval-status="UNMATCHED" />
    <keyphrase term="neoadjuvant endocrine therapy" eval-status="UNMATCHED" />
    <keyphrase term="randomized" eval-status="UNMATCHED" />
    <keyphrase term="contralateral breast" eval-status="UNMATCHED" />
    <keyphrase term="primary core analysis" eval-status="UNMATCHED" />
    <keyphrase term="distant recurrence" eval-status="UNMATCHED" />
    <keyphrase term="greater clinical benefit" eval-status="UNMATCHED" />
    <keyphrase term="years" eval-status="UNMATCHED" />
    <keyphrase term="therapy" eval-status="UNMATCHED" />
    <keyphrase term="antiestrogen therapy" eval-status="UNMATCHED" />
    <keyphrase term="time" eval-status="UNMATCHED" />
    <keyphrase term="superior" eval-status="UNMATCHED" />
    <keyphrase term="population" eval-status="UNMATCHED" />
    <keyphrase term="tumors" eval-status="UNMATCHED" />
    <keyphrase term="exclusion criteria" eval-status="UNMATCHED" />
    <keyphrase term="positive" eval-status="UNMATCHED" />
    <keyphrase term="recurrence" eval-status="UNMATCHED" />
  </prediction>
</evalitem>

